Indications
Therapeutic Asset Ratings
6,302 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Vorinostat
Acute Leukemia
University of Michigan Rogel Cancer Center
P1/2
CC
(46)
Wrair-Pam-Cf1
Cystic Fibrosis
National Institute of Allergy and Infectious Diseases (NIAID)
P1/2
CC
(46)
Zeprumetostat
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
Sun Yat-sen University
P1/2
CC
(46)
Zirconium Zr 89 Crefmirlimab Berdoxam
Urinary Bladder Neoplasm
AstraZeneca
P1/2
CC
(46)
zx-101a
Non-Hodgkin Lymphoma
Nanjing Zenshine Pharmaceuticals
P1/2
CC
(46)
zx-101a
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Nanjing Zenshine Pharmaceuticals
P1/2
CC
(46)
1.0% ip-001 for
Soft Tissue Sarcoma
Immunophotonics, Inc.
P1/2
CC
(45)
161tb rad402
Castration-Resistant Prostate Carcinoma
Radiopharm Theranostics, Ltd
P1/2
CC
(45)
177lu-betabart
Non-Small Cell Lung Carcinoma
Radiopharm Theranostics, Ltd
P1/2
CC
(45)
[177lu]lu-dpi-4452
Urothelial Carcinoma
ITM Oncologics GmbH
P1/2
CC
(45)
[18F]MC225
Neurodegenerative Disease
University Medical Center Groningen
P1/2
CC
(45)
18f-op-801
Amyotrophic Lateral Sclerosis
Ashvattha Therapeutics, Inc.
P1/2
CC
(45)
18f-op-801
Parkinson Disease
Ashvattha Therapeutics, Inc.
P1/2
CC
(45)
1H-ISOINDOL-1-ONE, 7-((6-((DIMETHYLAMINO)METHYL)-5-((3S)-TETRAHYDRO-3-FURANYL)-2-PYRIDINYL)AMINO)-4-(7-FLUOROIMIDAZO(1,2-A)PYRIDIN-3-YL)-2,3-DIHYDRO-
Renal Cell Carcinoma
Nimbus Saturn, Inc.
P1/2
CC
(45)
[203Pb]Pb-MP0712
Small Cell Lung Carcinoma
Molecular Partners AG
P1/2
CC
(45)
[203pb]pb-psv359
Mesothelioma
Perspective Therapeutics
P1/2
CC
(45)
[212pb]pb-psv359
Mesothelioma
Perspective Therapeutics
P1/2
CC
(45)
225ac-sso110
Cutaneous Neuroendocrine Carcinoma
Ariceum Therapeutics GmbH
P1/2
CC
(45)
225ac-sso110
Small Cell Lung Carcinoma
Ariceum Therapeutics GmbH
P1/2
CC
(45)
23me-00610
Small Cell Lung Carcinoma
23andMe, Inc.
P1/2
CC
(45)
23me-00610
Primary Peritoneal Carcinoma
23andMe, Inc.
P1/2
CC
(45)
3h-10000
Gastric Cancer
3H Pharmaceuticals Co., Ltd.
P1/2
CC
(45)
4SCAR123
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
4SCAR20
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
4SCAR22
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
Showing 3326 to 3350 of 6,302 assets
Previous
Page 134 of 253
Next